• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Dr Brandon Shank: Pharmacist Education on Biosimilars


Brandon Shank, PharmD, MPH, BCOP, Clinical Pharmacy Specialist, discusses the importance of pharmacist education on biosimilar treatments.

Transcript (Slightly Edited):

Education is paramount with the implementation of biosimilars for pharmacists. Currently, there is an education gap because the FDA is finalizing the naming documents and how these drugs will be approved and make it to market. As more drugs become available, this gap will close, and pharmacists will become more used to seeing these in practice and utilizing these agents. They will become more familiar with the packaging differences, the naming, and the indications of use. So, they will be able to dispense these products with confidence.

Related Videos
Lakesha Farmer, PharmD
Lakesha Farmer from Cencora
Jeffrey Casberg, RPh, MS.
Adam Colborn, JD.
Legal scale weighs profit as greater than medical treatment
Ha Kung Wong, JD.
Ha Kung Wong, JD
Cencora's Corey Ford
Related Content
© 2024 MJH Life Sciences

All rights reserved.